Mechanism of Action of Decitabine in the Treatment of Acute Myeloid Leukemia by Regulating LINC00599
Objective. Acute myeloid leukemia (AML) is a heterogeneous malignancy with a low long-term survival rate. The aim of this study was to investigate the effects of decitabine (DAC) treatment cell proliferation and apoptosis in AML and role of the expression of LINC00599 and, consequently, miR-135a-5p....
Saved in:
Main Authors: | Fan Du, Ting Jin, Li Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2023/2951519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness
by: Linu A. Jacob, et al.
Published: (2015-01-01) -
Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines
by: Sam Humphries, et al.
Published: (2025-01-01) -
Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia
by: Feng Wang, et al.
Published: (2025-01-01) -
Acute Myeloid Leukemia Presenting with Pulmonary Tuberculosis
by: Merlin Thomas, et al.
Published: (2014-01-01) -
Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract
by: Ryan M. Kahn, et al.
Published: (2019-01-01)